---
title: Confluence Discovery Technologies, Inc. vs Explicyte
slug_a: confluencediscovery
slug_b: explicyte
site: cro
review_signal_gate: closed
canonical_path: /compare/confluencediscovery/explicyte
---

# Confluence Discovery Technologies, Inc. vs Explicyte

Side-by-side profile data from each company listing on this directory.

## Confluence Discovery Technologies, Inc.

- Profile: [/companies/confluencediscovery](/companies/confluencediscovery)

Confluence Discovery Technologies, Inc. — Full-service drug discovery CRO specializing in cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, and in vivo efficacy models from idea through IND.

Services: 7. Modalities: 0. Indications: 1. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Discovery Research
- Medicinal Chemistry
- In Vitro Pharmacology
- In Vivo Efficacy Models
- Biomarker Assays
- Translational Research
- Immunology & Inflammation Services

### Modalities

- Data not yet provided.

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)

## Explicyte

- Profile: [/companies/explicyte](/companies/explicyte)

Explicyte — Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.

Services: 13. Modalities: 2. Indications: 1. Locations: 1. Certifications: 3. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.